Original article| Volume 23, ISSUE 6, P539-544, September 2012

Download started.


Brain natriuretic peptide is related to carotid plaques and predicts atherosclerosis in pre-dialysis patients with chronic kidney disease



      Although brain natriuretic peptide (BNP) concentration has been associated with atherosclerosis and ischemic cardiovascular diseases (CVD) in the general population, less is known about this relationship in pre-dialysis chronic kidney disease (CKD) patients.


      We prospectively analyzed 227 pre-dialysis patients with CKD [median estimated glomerular filtration rate (eGFR): 28.82 (11.65–48.20) ml/min/1.73 m2]. At enrollment, BNP concentrations, biochemical and echocardiographic parameters were measured, and carotid artery ultrasound was performed. Patients were prospectively followed for a mean 31.8 months (range 0.5–57.0 months). Ischemic CV events and patient outcomes were recorded.


      Median BNP concentration at enrollment was significantly higher in the CKD patients than in a control group [53.9 (16.2–181.0) pg/ml vs. 9.4 (7.0–15.3) pg/ml, P<0.01]. BNP concentration was positively related with the carotid intima–media thickness of the common carotid artery (CCA-IMT) and left ventricular mass index (LVMI) and was significantly higher in patients with than without carotid plaques (P<0.01). Logistic regression analysis confirmed that lgBNP concentration was independently correlated with carotid plaques. Thirty-two patients experienced ischemic cardiovascular (ICV) events during follow-up. Kaplan–Meier analysis showed that cumulative survival without new ICV events was better in patients with lower than with higher BNP concentrations (P<0.01). Cox regression analysis showed that BNP was an independent risk factor for ICV events (HR=3.167, 95%CI=1.398–7.171, P<0.01).


      Similar to findings in the general population, elevated BNP level is related to atherosclerosis and an increased risk of ICV events in pre-dialytic CKD patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Recio-Mayoral A.
        • Banerjee D.
        • Streather C.
        • Kaski J.C.
        Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease–a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.
        Atherosclerosis. 2011; 216: 446-451
        • Zyga S.
        • Christopoulou G.
        • Malliarou M.
        Malnutrition–inflammation–atherosclerosis syndrome in patients with end-stage renal disease.
        J Ren Care. 2011; 37: 12-15
        • Fujii H.
        • Nakai K.
        • Fukagawa M.
        Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
        Ther Apher Dial. 2011; 15: 125-128
        • Ang D.S.
        • Kong C.F.
        • Kao M.P.
        • Struthers A.D.
        Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
        Am Heart J. 2009; 158: 133-140
        • Orlowska-Baranowska E.
        • Baranowski R.
        • Greszata L.
        • Stepinska J.
        Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis.
        J Heart Valve Dis. 2008; 17: 598-605
        • de Lemos J.A.
        • McGuire D.K.
        • Khera A.
        • Das S.R.
        • Murphy S.A.
        • Omland T.
        • et al.
        Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
        Am Heart J. 2009; 157: 746-753
        • Niedner M.F.
        • Foley J.L.
        • Riffenburgh R.H.
        • Bichell D.P.
        • Peterson B.M.
        • Rodarte A.
        B-type natriuretic peptide: perioperative patterns in congenital heart disease.
        Congenit Heart Dis. 2010; 5: 243-255
        • Ashley K.E.
        • Galla J.M.
        • Nicholls S.J.
        Brain natriuretic peptides as biomarkers for atherosclerosis.
        Prev Cardiol. 2008; 11: 172-176
        • Safley D.M.
        • Awad A.
        • Sullivan R.A.
        • Sandberg K.R.
        • Mourad I.
        • Boulware M.
        • et al.
        Changes in B-type natriuretic peptide levels in hemodialysis and the effect of depressed left ventricular function.
        Adv Chronic Kidney Dis. 2005; 12: 117-124
        • Takami Y.
        • Horio T.
        • Iwashima Y.
        • Takiuchi S.
        • Kamide K.
        • Yoshihara F.
        • et al.
        Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF.
        Am J Kidney Dis. 2004; 44: 420-428
        • Vickery S.
        • Price C.P.
        • John R.I.
        • Abbas N.A.
        • Webb M.C.
        • Kempson M.E.
        • et al.
        B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
        Am J Kidney Dis. 2005; 46: 610-620
        • Mark P.B.
        • Stewart G.A.
        • Gansvoort R.T.
        • Petrie C.J.
        • McDonagh T.A.
        • Dargie H.J.
        • et al.
        Diagnostic potential of circulating natriuretic peptides in chronic kidney disease.
        Nephrol Dial Transplant. 2006; 21: 402-410
        • Spanaus K.S.
        • Kronenberg F.
        • Ritz E.
        • Schlapbach R.
        • Fliser D.
        • Hersberger M.
        • et al.
        B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
        Clin Chem. 2007; 53: 1264-1272
        • Hedvig J.
        • Podracká L.
        • Potoceková D.
        Elevated brain natriuretic peptide is associated with abnormal heart geometry in children with chronic kidney disease.
        Kidney Blood Press Res. 2010; 33: 87-93
        • Stompór T.
        • Kraśniak A.
        • Sułowicz W.
        • Dembińska-Kieć A.
        • Janda K.
        • Wójcik K.
        • et al.
        Changes in common carotid artery intima–media thickness over 1 year in patients on peritoneal dialysis.
        Nephrol Dial Transplant. 2005; 20: 404-412
        • Tabbibizar R.
        • Maisel A.
        The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure.
        Curr Opin Cardiol. 2002; 17: 340-345
        • Krüger S.
        • Graf J.
        • Merx M.W.
        • Stickel T.
        • Kunz D.
        • Koch K.C.
        • et al.
        The value of cardiopulmonary exercise testing and brain natriuretic peptide plasma levels in predicting the prognosis of patients with chronic heart failure.
        Eur J Intern Med. 2006; 17: 96-101
        • Wang A.Y.
        • Sanderson J.E.
        Current perspectives on diagnosis of heart failure in long-term dialysis patients.
        Am J Kidney Dis. 2011; 57: 308-319
        • Sun L.
        • Sun Y.
        • Zhao X.
        • Xu C.
        • Chen D.
        • Li L.
        • et al.
        Predictive role of BNP and NT-proBNP in hemodialysis patients.
        Nephron Clin Pract. 2008; 110: c178-c184
        • Takahashi T.
        • Nakamura M.
        • Onoda T.
        • Ohsawa M.
        • Tanno K.
        • Itai K.
        • et al.
        Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study.
        Atherosclerosis. 2009; 207: 298-303
        • DeFilippi C.R.
        • Fink J.C.
        • Nass C.M.
        • Chen H.
        • Christenson R.
        N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
        Am J Kidney Dis. 2005; 46: 35-44
        • Khan I.A.
        • Fink J.
        • Nass C.
        • Chen H.
        • Christenson R.
        • deFilippi C.R.
        N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
        Am J Cardiol. 2006; 97: 1530-1534
        • Tomonori T.
        • Keiko S.
        • Shinkichi H.
        • Yoji N.
        • Akira T.
        Carotid atherosclerosis and arterial peripheral pulse wave velocity in cerebral thrombosis.
        J Clin Neurosci. 2006; 13: 45-49
        • Alexander M.R.
        • Knowles J.W.
        • Nishikimi T.
        • Maeda N.
        Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A−/−apolipoprotein E−/− mice.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1077-1082
        • Casco V.H.
        • Veinot J.P.
        • Kuroski de Bold M.L.
        • Masters R.G.
        • Stevenson M.M.
        • de Bold A.J.
        Natriuretic peptide system gene expression in human coronary arteries.
        J Histochem Cytochem. 2002; 50: 799-809
        • Kohno M.
        • Yokokawa K.
        • Yasunari K.
        • Kano H.
        • Minami M.
        • Ueda M.
        • et al.
        Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells.
        Circ Res. 1997; 81: 585-590
        • Deng Y.J.
        • Tan N.
        • Zeng H.K.
        • Fu Y.H.
        • Dong X.L.
        Effects of BNP preconditioning on myocardial cell apoptosis and expressions of bcl-2 and Bax during myocardial ischemia-reperfusion injury in rats.
        Zhonghua Yi Xue Za Zhi. 2010; 90: 3431-3434
        • Ikeda N.
        • Nakamura M.
        • Yazaki Y.
        • Ono T.
        • Yamamoto M.
        • Ito S.
        • et al.
        A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function.
        Heart Vessels. 2011; 26: 473-479
        • Rasić S.
        • Hadzović-Dzuvo A.
        • Tomić M.
        • Uncanin S.
        • Corić S.
        Impact of hemoglobin concentration on plasma B-type natriuretic peptide level and left ventricle echocardiographics characteristics in chronic kidney disease patients.
        Coll Antropol. 2009; 33: 141-144
        • Akanji A.O.
        • Suresh C.G.
        • Al-Radwan R.
        • Fatania H.R.
        Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
        Metab Syndr Relat Disord. 2009; 7: 563-569
        • Nakamura M.
        • Endo H.
        • Nasu M.
        • Arakawa N.
        • Segawa T.
        • Hiramori K.
        Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.
        Heart. 2002; 87: 131-135
        • Niinuma H.
        • Nakamura M.
        • Hiramori K.
        Plasma B-type natriuretic peptide measurement in a multiphasic health screening program.
        Cardiology. 1998; 90: 89-94
        • Seki S.
        • Tsurusaki T.
        • Kasai T.
        • Taniguchi I.
        • Mochizuki S.
        • Yoshimura M.
        Clinical significance of B-type natriuretic peptide in the assessment of untreated hypertension.
        Circ J. 2008; 72: 770-777